United States · Who invested in UNUM Therapeutics?
UNUM Therapeutics's investors include Atlas Venture, F-Prime Capital, Sanofi-Genzyme BioVentures, Wellington Management and New Leaf Venture Partners, and 8 more on record.
2015
$12MSeries A$65MSeries BUnited States · Series B startup
Who invested in UNUM Therapeutics
2 rounds we have observed, with the 13 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$77Mraised across 2 rounds since 2014, from 2 sources
$12MSeries A$65MSeries B
- Latest round
- Series B, $65MJun 2015
- Step-upi
- 5.4×
- Investors
- 13
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $12M Oct 2014
- Biggest round
- $65M Series B · Jun 2015
- Between rounds
- 8 months from the last two
The rounds
- Jun 2015Series B$65M9 new3 returning
Atlas Venture
Wellington Management
F-Prime Capital
New Leaf Venture Partners- Novo Holdings A/S
Jennison Associates
Sanofi-Genzyme BioVentures
Sectoral Asset Management- Sabby Capital
Brace Pharma- Cowen Investments
- Seattle Genetics
From a historical funding recordSEC filing: $65M sold, first sale Jun 2015
- Oct 2014Series A$12M4 new
From a historical funding recordSEC filing: $6.3M sold, first sale Oct 2014
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Novo Holdings A/SGrowth equity1round
Fidelity BiosciencesInvestment firm1round
Sabby CapitalPrivate equity1round
Cowen InvestmentsGrowth equity1round
Seattle Geneticsno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about UNUM Therapeutics
How much has UNUM Therapeutics raised?
UNUM Therapeutics has raised $77M across 2 rounds since 2014.
When did UNUM Therapeutics last raise?
UNUM Therapeutics's most recent round was a Series B of $65M in Jun 2015.
What was UNUM Therapeutics's biggest round?
Its most recent round, $65M in Jun 2015, is also its largest on record.
Who backed UNUM Therapeutics first?
UNUM Therapeutics's first round on record, in Oct 2014, was backed by Atlas Venture, F-Prime Capital and Fidelity Biosciences and 1 others.
What stage is UNUM Therapeutics at?
UNUM Therapeutics's latest named round is a Series B, in Jun 2015.
Where is UNUM Therapeutics based?
UNUM Therapeutics is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.